With regards to the possibility that NTRK3 could act as a tumor suppressor gene in the colon rather than as an oncogene, somatic inactivating mutations of NTRK3 have been identified in CRC [15], as well as in other cancers including breast, lung, and pancreatic [16]. Here, NTRK3 is linked to colorectal carcinoma.